SB Al Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.
MFDS item code 201904509 · Approved 2019.07.02
This product's status changed to Expired on 2024.07.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
This medication is used for gastrointestinal diseases such as ulcers of the stomach and duodenum, gastritis, and gastroesophageal reflux disease. It is also effective for conditions where excessive gastric acid secretion is a problem, such as Zollinger-Ellison syndrome. It helps prevent postoperative ulcers and treats gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to prevent Mendelson's syndrome when given before anesthesia. It is indicated for the treatment and prevention of various diseases related to the stomach.
○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, without regard to meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent the development of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs generally heal within 4 weeks, and ulcers generally heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used in patients with impaired kidney function or those undergoing dialysis. It should also not be administered to patients with allergies to this drug or its components, or those with a history of acute porphyria. It is safe not to use in patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, and in premature or neonatal infants. Patients who must restrict potassium intake should not take this medication. It should be used cautiously in patients with liver dysfunction or a history of drug allergies, elderly patients, and those with a history of kidney impairment. Patients taking non-steroidal anti-inflammatory drugs should have regular examinations, especially elderly patients or those with a history of peptic ulcers. This medication may mask symptoms of stomach cancer, so patients with gastric ulcers or those experiencing new or altered dyspeptic symptoms who are middle-aged or older should have malignancy ruled out before treatment. For patients with gastric or duodenal ulcers infected with Helicobacter pylori, therapy to eradicate the bacteria should be administered concurrently. Care should be taken when administering to severely ill patients in an intensive care unit, patients with hypophosphatemia, or those who have difficulty swallowing. During treatment with this medication, allergic reactions or shock symptoms, skin rashes, breathing difficulties, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, neurological disturbances, myalgia, skin abnormalities, and other side effects may occur, so if abnormal symptoms appear, immediate consultation with a physician is necessary. Do not take this medication long-term, and monitor symptoms and blood, liver, and kidney function periodically during treatment. Elderly patients or those with chronic lung disease, diabetes, or weakened immune systems may be at an increased risk of pneumonia when taking this medication, so care is warranted. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may affect the absorption or metabolism of other drugs, so dosage adjustments or discontinuation of concurrently taken medications may be necessary; inform your doctor or pharmacist. Particular caution should be taken regarding interactions with this medication and specific antibiotics, anticoagulants, anticonvulsants, etc., so intervals between doses should be adjusted or avoided. It is safest not to take this medication during pregnancy or while breastfeeding. Safety and efficacy have not been established for pediatric patients, so its use in children is not recommended. This medication may cause false-positive results in urine protein tests, so care is needed during testing. In the case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and if needed, blood dialysis can be performed to remove it. This medication reduces gastric acid secretion and may promote bacterial growth in the gastrointestinal tract, so ophthalmological exams may be necessary with long-term use.
Anaphylactic shock, skin rash, hives, angioedema, fever, bronchospasm, hypotension, chest pain, granulocytopenia, leukopenia, thrombocytopenia, elevated serum enzyme levels, agranulocytosis, pancytopenia, myelofibrosis, aplastic anemia, aplastic anemia, acquired immune hemolytic anemia, eosinophilia, transient and reversible increases in AST, ALT, r-GTP, ALP, jaundice hepatitis, non-jaundice hepatitis, tachycardia, bradycardia, atrioventricular block, premature ventricular contractions, arrhythmias, vasculitis, nausea, vomiting, constipation, diarrhea, abdominal distension, abdominal pain, loss of appetite, dizziness, drowsiness, confusion, convulsions, agitation, insomnia, headache, feeling of heaviness in the head, illness, anxiety, mental confusion, depression, hallucinations, blurred vision, involuntary movement disorders, consciousness disturbances, spasticity, gynecomastia, galactorrhea, erectile dysfunction, decreased libido, arthralgia, myalgia, rhabdomyolysis, alopecia, glossitis, pruritus, acute interstitial nephritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from getting in, and it is best kept at room temperature between 1 degree and 30 degrees Celsius. By storing it this way, the medication's efficacy can be maintained for a longer period.
Green round film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.